Purine Antagonists for Chronic Lymphocytic Leukaemia-Reference-Cited by-同舟云学术

Purine Antagonists for Chronic Lymphocytic Leukaemia

Published:2006-07-19 Issue:4 Volume:2012 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Steurer Michael¹,Pall Georg²,Richards Sue³,Schwarzer Guido⁴,Bohlius Julia⁵,Greil Richard⁶

Affiliation:

1. Innsbruck University Hospital; Division of Haematology & Oncology; Anichstrasse 35 A-6020 Innsbruck Austria

2. University Clinic Innsbruck; Internal Medicine; Anichstrasse 35 Innsbruck Austria 6020

3. Oxford University; Clinical Trials Services Unit; Woodstock Road Oxford UK OX2 6HE

4. Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg; German Cochrane Centre; Stefan-Meier-Str. 26 Freiburg Germany D-79104

5. University of Bern; Institute of Social and Preventive Medicine; Finkenhubelweg 11 Bern Switzerland 3012

6. St. Johann Hospita - Paracelsus University; Third Mediacl Deapartment; Muellner Hauptstrasse 48 Salzburg Austria 5020

Publisher

Wiley

Subject

Pharmacology (medical)

Reference39 articles.

1. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL;Johnson;Lancet,1996

2. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients;Leporrier;Blood,2001

3. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia;Rai;New England Journal of Medicine,2000

4. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial;Robak;Blood,2000

5. Spriano M Chiurazzi F Liso V Mazza P Molica S Gobbi M Multicentre prospective randomized trial of fludarabine versus chlorambucil and prednisone in previously untreated patients with active B-CLL Hematology and Cell Therapy 2000 93 11036943

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures;American Journal of Hematology;2021-11-24

2. Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia;Cochrane Database of Systematic Reviews;2021-09-17

3. The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota;Toxicology;2021-08

4. Oxidative stress mediated cytotoxicity in leukemia cells induced by active phyto-constituents isolated from traditional herbal drugs of West Bengal;Journal of Ethnopharmacology;2020-04

5. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment;American Journal of Hematology;2019-10-04